Bromantane (Ladasten) – Information for Doctors
12 Feb 2017
The new drug with stimulant and anxiolytic properties Ladasten the treatment of neurasthenia (results of comparative clinical studies with placebo)
Application Ladasten drug in the treatment of asthenic disorders postinfectious
Influence Ladasten on psychophysiological state characteristics and cognitive function in patients with psychogenic asthenic disorders
Safety and therapeutic efficacy Ladasten drug in patients with neurasthenia and asthenia somatogenetic
Cognitive impairment in somatogenetic asthenia: efficiency Ladasten.
A new approach to the treatment of neurasthenia and asthenia somatogenetic (results of a multicenter study of efficacy and safety Ladasten)